XML 26 R81.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segment Data (Schedule of Net Sales from External Customers by Products) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 26, 2015
Jun. 27, 2014
Jun. 26, 2015
Jun. 27, 2014
Segment Reporting Information [Line Items]        
Net sales $ 965.1 $ 653.1 $ 2,741.3 $ 1,751.1
Operating Segments        
Segment Reporting Information [Line Items]        
Net sales [1] 955.7 641.4 2,712.5 1,716.2
Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 446.2 84.9 1,154.1 199.6
Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 307.9 329.4 954.9 848.5
Operating Segments | Global Medical Imaging        
Segment Reporting Information [Line Items]        
Net sales 201.6 227.1 603.5 668.1
H. P. Acthar Gel | Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 268.7 0.0 763.1 0.0
Ofirmev | Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 62.1 53.2 201.6 58.5
Inomax | Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 81.5 0.0 81.5 0.0
Exalgo | Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 8.6 8.6 32.7 73.7
Other | Operating Segments | Specialty Brands        
Segment Reporting Information [Line Items]        
Net sales 25.3 23.1 75.2 67.4
Other | Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 51.5 41.2 162.4 108.8
Other | Operating Segments | Global Medical Imaging        
Segment Reporting Information [Line Items]        
Net sales 34.3 40.7 105.8 121.5
Oxycodone (API) | Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 31.6 53.8 127.2 101.7
Hydrocodone (API) | Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 37.4 25.3 138.0 75.1
Methylphenidate ER (Specialty Generics) | Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 30.0 54.7 112.6 154.3
Other Controlled Substances | Operating Segments | Specialty Generics        
Segment Reporting Information [Line Items]        
Net sales 157.4 154.4 414.7 408.6
Optiray (CMDS) | Operating Segments | Global Medical Imaging        
Segment Reporting Information [Line Items]        
Net sales 58.5 76.0 177.5 219.4
Contrast Media and Delivery Systems | Operating Segments | Global Medical Imaging        
Segment Reporting Information [Line Items]        
Net sales 92.8 116.7 283.3 340.9
Nuclear Imaging | Operating Segments | Global Medical Imaging        
Segment Reporting Information [Line Items]        
Net sales $ 108.8 $ 110.4 $ 320.2 $ 327.2
[1] Amounts represent sales to external customers.